Janne T. Backman

16.2k total citations · 2 hit papers
213 papers, 12.5k citations indexed

About

Janne T. Backman is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Janne T. Backman has authored 213 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Pharmacology, 94 papers in Oncology and 55 papers in Pharmacology. Recurrent topics in Janne T. Backman's work include Pharmacogenetics and Drug Metabolism (105 papers), Drug Transport and Resistance Mechanisms (80 papers) and Pharmacological Effects and Toxicity Studies (48 papers). Janne T. Backman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (105 papers), Drug Transport and Resistance Mechanisms (80 papers) and Pharmacological Effects and Toxicity Studies (48 papers). Janne T. Backman collaborates with scholars based in Finland, Germany and Sweden. Janne T. Backman's co-authors include Pertti J. Neuvonen, Mikko Niemi, Mikko Neuvonen, Jouko Laitila, Klaus T. Olkkola, Aleksi Tornio, Kari T. Kivistö, Anne M. Filppula, Lauri Kajosaari and Wen Xia and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Janne T. Backman

208 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance

2006 635 citations Pertti J. Neuvonen, Mikko Niemi et al. Clinical Pharmacology & Therapeutics profile →
Pharmacokinetic Interactions with Rifampicin

2003 586 citations Mikko Niemi, Janne T. Backman et al. profile →

Peers

Janne T. Backman

PHARM

ONCOL

PPCH

PHARM

SURGE

Mikko Niemi Finland

Amin Rostami‐Hodjegan United Kingdom

Martin F. Fromm Germany

Paul B. Watkins United States

David A. Flockhart United States

Kenneth E. Thummel United States

Richard B. Kim Canada

Ulrich M. Zanger Germany

Ivar Roots Germany

Steven Wrighton United States

Mikko Niemi Finland

Janne T. Backman

5.5k ×1.0

PHARM

6.2k ×1.4

ONCOL

3.2k ×1.3

PPCH

1.5k ×0.8

PHARM

3.2k ×1.7

SURGE

Citations per year, relative to Janne T. Backman Janne T. Backman (= 1×) peers Mikko Niemi

Countries citing papers authored by Janne T. Backman

Since Specialization

Citations

This map shows the geographic impact of Janne T. Backman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janne T. Backman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janne T. Backman more than expected).

Fields of papers citing papers by Janne T. Backman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janne T. Backman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janne T. Backman. The network helps show where Janne T. Backman may publish in the future.

Co-authorship network of co-authors of Janne T. Backman

This figure shows the co-authorship network connecting the top 25 collaborators of Janne T. Backman. A scholar is included among the top collaborators of Janne T. Backman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janne T. Backman. Janne T. Backman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Backman, Janne T., et al.. (2024). Misfolding of transthyretin in vivo is controlled by the redox environment and macromolecular crowding. Journal of Biological Chemistry. 301(1). 108031–108031. 2 indexed citations

Neuvonen, Mikko, et al.. (2024). Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and Translational Science. 17(3). e13773–e13773. 3 indexed citations

Tarkiainen, E. Katriina, Mikko Neuvonen, Maria Paile‐Hyvärinen, et al.. (2024). Genome‐Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical Pharmacology & Therapeutics. 115(6). 1428–1440. 7 indexed citations

Neuvonen, Mikko, et al.. (2024). Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors. European Journal of Pharmaceutical Sciences. 198. 106735–106735. 5 indexed citations

Backman, Janne T., et al.. (2023). Drug‐related deaths in a university hospital: Comparison to previous decades. Basic & Clinical Pharmacology & Toxicology. 134(1). 165–174.

Wester, Niklas, Terhi J. Lohela, Mika Kurkela, et al.. (2023). Introduction of an electrochemical point‐of‐care assay for quantitative determination of paracetamol in finger‐prick capillary whole blood samples. British Journal of Clinical Pharmacology. 89(9). 2933–2938. 2 indexed citations

Simonen, Piia, Heli Tolppanen, Otto Hartman, et al.. (2023). The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction. SHILAP Revista de lepidopterología. 53. 26–32. 3 indexed citations

Kortelainen, Jukka, Eero Väyrynen, Jouko Laurila, et al.. (2016). Pilot Study of Propofol-induced Slow Waves as a Pharmacologic Test for Brain Dysfunction after Brain Injury. Anesthesiology. 126(1). 94–103. 6 indexed citations

Filppula, Anne M., Jouko Laitila, Pertti J. Neuvonen, & Janne T. Backman. (2011). Potent mechanism‐based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates. British Journal of Pharmacology. 165(8). 2787–2798. 79 indexed citations

10.

Shyamsundar, Murali, Scott McKeown, Cecilia O’Kane, et al.. (2009). Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy Volunteers. American Journal of Respiratory and Critical Care Medicine. 179(12). 1107–1114. 194 indexed citations

11.

Xiang, Xiaoqiang, Yi Han, Mikko Neuvonen, et al.. (2009). Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. Pharmacogenetics and Genomics. 19(6). 447–457. 49 indexed citations

12.

Jönsson, Siv, et al.. (2007). Developmental pharmacokinetics of ciclosporin – a population pharmacokinetic study in paediatric renal transplant candidates. British Journal of Clinical Pharmacology. 64(6). 772–784. 61 indexed citations

13.

Rautiainen, Henna, Martti Färkkilâ, Mikko Neuvonen, et al.. (2006). Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis. Alimentary Pharmacology & Therapeutics. 24(11-12). 1545–1552. 15 indexed citations

14.

Tornio, Aleksi, Pertti J. Neuvonen, & Janne T. Backman. (2006). The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. European Journal of Clinical Pharmacology. 62(8). 645–651. 17 indexed citations

15.

Neuvonen, Pertti J., Mikko Niemi, & Janne T. Backman. (2006). Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance. Clinical Pharmacology & Therapeutics. 80(6). 565–581. 635 indexed citations breakdown →

16.

Jaakkola, Tiina, Janne T. Backman, Mikko Neuvonen, & Pertti J. Neuvonen. (2005). Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Clinical Pharmacology & Therapeutics. 77(5). 404–414. 97 indexed citations

17.

Tornio, Aleksi, Marja K. Pasanen, Jouko Laitila, Pertti J. Neuvonen, & Janne T. Backman. (2005). Comparison of 3‐Hydroxy‐3‐methylglutaryl Coenzyme A (HMG‐CoA) Reductase Inhibitors (Statins) as Inhibitors of Cytochrome P450 2C8. Basic & Clinical Pharmacology & Toxicology. 97(2). 104–108. 31 indexed citations

18.

Xia, Wen, Liguo Shen, Janne T. Backman, Jouko Laitila, & Pertti J. Neuvonen. (2002). Trimethoprim and Sulfamethoxazole are Selective Inhibitors of CYP2C8 and CYP2C9, Respectively. Drug Metabolism and Disposition. 30(6). 631–635. 134 indexed citations

19.

Varis, Tiina, et al.. (2001). Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo. European Journal of Clinical Pharmacology. 57(6-7). 457–460. 26 indexed citations

20.

Kivistö, Kari T., et al.. (1997). Triazolam is ineffective in patients taking rifampin. Clinical Pharmacology & Therapeutics. 61(1). 8–14. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact